MedPath

NYU LANGONE HEALTH

NYU LANGONE HEALTH logo
🇺🇸United States
Ownership
Private
Established
1841-01-01
Employees
10K
Market Cap
-
Website
http://www.nyulangone.org

Pembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the Bladder

Phase 2
Active, not recruiting
Conditions
Muscle-invasive Urothelial Cancer of the Bladder
Interventions
Procedure: Transurethral Resection of Bladder Tumor
Radiation: External Beam Radiation Therapy
First Posted Date
2015-12-03
Last Posted Date
2024-10-28
Lead Sponsor
NYU Langone Health
Target Recruit Count
60
Registration Number
NCT02621151
Locations
🇺🇸

University of Chicago, Chicago, Illinois, United States

🇺🇸

NYU Perlmutter Cancer Center, New York, New York, United States

🇺🇸

Memorial Sloan Kettering, New York, New York, United States

and more 2 locations

Cognitive Detection of Preclinical AD: Validation Using Biomarkers

Completed
Conditions
Mild Cognitive Impairment
First Posted Date
2015-11-30
Last Posted Date
2021-01-15
Lead Sponsor
NYU Langone Health
Target Recruit Count
81
Registration Number
NCT02616679
Locations
🇺🇸

NYU Langone Medical Center, New York, New York, United States

The Safety, Tolerability and Efficacy of Dronabinol, for the Treatment of Nausea and Vomiting in Familial Dysautonomia

Phase 2
Withdrawn
Conditions
Vomiting
Familial Dysautonomia
Nausea
Interventions
Other: Placebo
First Posted Date
2015-11-20
Last Posted Date
2019-06-13
Lead Sponsor
NYU Langone Health
Registration Number
NCT02608931
Locations
🇺🇸

NYU Medical Center, New York, New York, United States

Oral Care Protocol for the Management of Chemotherapy and Radiation Therapy-Induced Oral Mucositis

Not Applicable
Completed
Conditions
Oral Cancer
Oral Mucositis
Interventions
Procedure: Standard of Care Oral Hygiene Instructions
Procedure: Oral Mucosa Deterging and Periodontal Debridement (OMDP)
Procedure: Dental scaling, ultrasonic
Other: Chlorhexidine
First Posted Date
2015-11-20
Last Posted Date
2020-08-28
Lead Sponsor
NYU Langone Health
Target Recruit Count
19
Registration Number
NCT02608879
Locations
🇺🇸

NYU Langone Medical Center, New York, New York, United States

Neurotrack Test Validation Protocol

Completed
Conditions
Mild Cognitive Impairment
First Posted Date
2015-11-18
Last Posted Date
2019-12-20
Lead Sponsor
NYU Langone Health
Target Recruit Count
81
Registration Number
NCT02608021
Locations
🇺🇸

NYU Langone Medical Center, New York, New York, United States

Accelerated Intensity Modulated Radiation Therapy (AIMRT) to the Breast After Segmental Mastectomy

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Radiation: Accelerated intensity modulated radiation therapy (AIMRT)
First Posted Date
2015-11-17
Last Posted Date
2020-08-14
Lead Sponsor
NYU Langone Health
Target Recruit Count
314
Registration Number
NCT02606708
Locations
🇺🇸

NYU Langone Medical Center, New York, New York, United States

NRX-1074 in Early Course Schizophrenia

Phase 2
Withdrawn
Conditions
Schizophrenia
Interventions
Drug: Placebo
First Posted Date
2015-11-11
Last Posted Date
2016-02-05
Lead Sponsor
NYU Langone Health
Registration Number
NCT02603458
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

🇺🇸

New York University Langone Medical Center/ Bellevue Hospital, New York, New York, United States

Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency Departments

Not Applicable
Completed
Conditions
Opioid Dependence
Interventions
Behavioral: Strengths-based Case Management (SBCM)
Behavioral: Screening, Assessment, and Referral (SAR)
First Posted Date
2015-10-27
Last Posted Date
2020-05-05
Lead Sponsor
NYU Langone Health
Target Recruit Count
300
Registration Number
NCT02586896
Locations
🇺🇸

Bellevue Hospital Center, New York, New York, United States

Evaluation of Salt Sensitivity in Young Adults

Not Applicable
Completed
Conditions
Healthy Volunteers
Interventions
Dietary Supplement: Salt tablet
First Posted Date
2015-10-27
Last Posted Date
2016-05-19
Lead Sponsor
NYU Langone Health
Target Recruit Count
40
Registration Number
NCT02588352
Locations
🇺🇸

NYU Langone Medical Center, New York, New York, United States

Protocol for Staged Stereotactic Radiosurgery for Large Arteriovenous Malformations

Not Applicable
Completed
Conditions
Intracranial Arteriovenous Malformations (AVM)
Interventions
Procedure: Fractionated stereotactic radiosurgery
Device: Leskell gamma unit
First Posted Date
2015-10-15
Last Posted Date
2023-11-07
Lead Sponsor
NYU Langone Health
Target Recruit Count
18
Registration Number
NCT02576535
© Copyright 2025. All Rights Reserved by MedPath